Spedizione con corriere espresso GLS a prezzi stracciati: gratuita con 90 € di spesa, altrimenti a 1, 2 o 3 € in base all'importo dell'ordine!

Categorie

The End of Alzheimer’s: The Brain and Beyond, 2nd edition di Lewis, Trempe

Nostro prezzo € 55,05 € 57,95 -5%
Disponibilità: Ordinabile in 7-10 giorni lavorativi

Quantità Descrizione

Acquisto di GRUPPO?? Se volete risparmiare contattateci!

Autore: Lewis, Trempe
Editore: Elsevier UK
Data di Pubblicazione: 2017
ISBN: 9780128121122
Pagine: 472


The End of Alzheimer’s: The Brain and Beyond, Second Edition is the first comprehensive overview on the molecular basis of Alzheimer’s outside of the brain, merging the most recent findings within the field into a single book. It aims to educate the reader on the many overlooked aspects of Alzheimer’s disease that occur outside the brain. This book uniquely provides step-by-step, peer-reviewed evidence that the current research model may be misguided and that a new and emerging model is more accurate. It carefully outlines the molecular research in Alzheimer’s outside the brain and argues that a more thorough, whole-body diagnosis will provide better answers about its causes and lead to new treatments. It is beneficial to researchers who need to be apprised of the emerging science on the causes of Alzheimer’s, and will hopefully redirect many into new avenues of cellular research and discovery.

  • Comprehensive literature-based summary of the current state of molecular Alzheimer’s disease research
  • Details the shortcomings of the prevailing model and therapeutics in development
  • Reviews blood-based biomarkers for Alzheimer’s and their link to amyloid- and Tau-independent causes outside the brain
  • Describes the tissues outside the brain impacted by Alzheimer’s and the underlying molecular causes
  • Explains the whole-body risks associated with Alzheimer’s, along with concomitant measures to slow or prevent the disease
  • Provides a protocol to properly research, evaluate, measure, diagnose, and potentially treat Alzheimer’s patients